Research / ATR / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-19-000824 General Corporate
Debt relative to revenue 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
40.73% · OPTIONAL · VALID
Capex intensity 83th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.64% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
11.34% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth 86th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
11.97% · CORE · VALID
Inventory pressure 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.78% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
28.77% · CORE · NOT_ENOUGH_HISTORY
Operating margin 6th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
10.35% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.72% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 56th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Dec 31, 2018 6/9 normalized Level 3 Mar 31, 2019 6/7 normalized Level 3 Jun 30, 2019 6/7 normalized Level 3 Sep 30, 2019 7/7 normalized Level 3 Dec 31, 2019 7/9 normalized Level 3 Mar 31, 2020 7/7 normalized Level 3 Jun 30, 2020 7/7 normalized Level 3 Sep 30, 2020 7/7 normalized Level 3 Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Sep 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 169.99%
Current 40.73%
Delta -129.26% Capex Intensity Decreased
Previous 8.05%
Current 7.64%
Delta -0.41% Cash Generation Increased
Previous 8.27%
Current 11.34%
Delta 3.07% Growth Increased
Previous 6.64%
Current 11.97%
Delta 5.33% Inventory Pressure Decreased
Previous 59.22%
Current 13.78%
Delta -45.43% Profitability Increased
Previous 9.18%
Current 10.35%
Delta 1.18% Sbc Intensity Increased
Previous 0.59%
Current 0.71%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.